why choose us

First received: December 12, 2023

Clinical Trial: Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Kidney Disease (CKD)

Study Type: OBSERVATIONAL


Official Title: OPTIMISE-CKD CEE: A Multinational, Observational, Secondary Data Study Describing Management and Treatment With Dapagliflozin in Routine Clinical Practice Among Patients With Chronic Kidney Disease in

Brief Summary: The OPTIMISE-CKD CEE study design will create a real-world evidence platform that systematically leverages the routine data collection made by Investigators and will help obtain relevant insights from clinical practice.This study is likely to include a more heterogeneous population compared with the constraints required by interventional study protocols.Treatment decisions, clinical outcomes, and common treatment scenarios in the context of routine care of CKD are likely to be more generalizable than those from…

Read more